Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PH motifs in PAR1&2 endow breast cancer growth.
Kancharla A, Maoz M, Jaber M, Agranovich D, Peretz T, Grisaru-Granovsky S, Uziely B, Bar-Shavit R. Kancharla A, et al. Nat Commun. 2015 Nov 24;6:8853. doi: 10.1038/ncomms9853. Nat Commun. 2015. PMID: 26600192 Free PMC article.
G Protein-Coupled Receptors in Cancer.
Bar-Shavit R, Maoz M, Kancharla A, Nag JK, Agranovich D, Grisaru-Granovsky S, Uziely B. Bar-Shavit R, et al. Among authors: kancharla a. Int J Mol Sci. 2016 Aug 12;17(8):1320. doi: 10.3390/ijms17081320. Int J Mol Sci. 2016. PMID: 27529230 Free PMC article. Review.
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects.
Bai H, Padron AS, Deng Y, Liao YJ, Murray CJ, Ontiveros C, Kari SJ, Kancharla A, Kornepati AVR, Garcia M, Reyes RM, Gupta HB, Conejo-Garcia JR, Curiel T. Bai H, et al. Among authors: kancharla a. J Immunother Cancer. 2023 Feb;11(2):e004871. doi: 10.1136/jitc-2022-004871. J Immunother Cancer. 2023. PMID: 36759012 Free PMC article.
25 results